Literature DB >> 21779887

Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.

M Björkholm1, M Kalin, P Grane, F Celsing.   

Abstract

A 59-year-old male with acute lymphoblastic leukemia developed sinus, tracheobroncheal, pulmonary, and intracerebral aspergillosis. All lesions except the intracerebral aspergillosis healed after combination antifungal treatment. Long-term voriconazole--but not posaconazole--therapy induced partial regression of the cerebral manifestations. At the time of writing, 3.5 years after the initial diagnosis, the patient is working half-time and suffers from a possible voriconazole-induced polyneuropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779887     DOI: 10.1007/s15010-011-0158-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

2.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 3.  Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.

Authors:  O A Cornely
Journal:  Infection       Date:  2008-07-19       Impact factor: 3.553

4.  Factors associated with overall and attributable mortality in invasive aspergillosis.

Authors:  Yasmine Nivoix; Michel Velten; Valérie Letscher-Bru; Alireza Moghaddam; Shanti Natarajan-Amé; Cécile Fohrer; Bruno Lioure; Karin Bilger; Philippe Lutun; Luc Marcellin; Anne Launoy; Guy Freys; Jean-Pierre Bergerat; Raoul Herbrecht
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

Review 5.  Fungal CNS infections in patients with hematologic malignancy.

Authors:  Livio Pagano; Morena Caira; Paolo Falcucci; Luana Fianchi
Journal:  Expert Rev Anti Infect Ther       Date:  2005-10       Impact factor: 5.091

6.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Painful peripheral neuropathy associated with voriconazole use.

Authors:  Sotirios Tsiodras; Rodesa Zafiropoulou; Efthymia Kanta; Christos Demponeras; Nikos Karandreas; Emanuel K Manesis
Journal:  Arch Neurol       Date:  2005-01

8.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

9.  Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer.

Authors:  R Y Hachem; M R Boktour; H A Hanna; R Husni; E Y Hanna; X Keutgen; B Shukrallah; I I Raad
Journal:  Infection       Date:  2008-08-25       Impact factor: 3.553

Review 10.  Cerebral aspergillosis: tissue penetration is the key.

Authors:  S Schwartz; E Thiel
Journal:  Med Mycol       Date:  2009-02-28       Impact factor: 4.076

View more
  4 in total

1.  CNS Mold Infections.

Authors:  Jennifer L Lyons
Journal:  Curr Infect Dis Rep       Date:  2013-10-13       Impact factor: 3.725

2.  An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.

Authors:  Cau D Pham; Shawn R Lockhart
Journal:  Curr Fungal Infect Rep       Date:  2012-12-16

Review 3.  Aspergillosis of central nervous system in patients with leukemia and stem cell transplantation: a systematic review of case reports.

Authors:  Aref Shariati; Mojtaba Didehdar; Shahin Rajaeih; Alireza Moradabadi; Mohammad Ghorbani; Vahid Falahati; Zahra Chegini
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-06-15       Impact factor: 3.944

Review 4.  Histopathological implications of Aspergillus infection in lung.

Authors:  Naobumi Tochigi; Yoichiro Okubo; Tsunehiro Ando; Megumi Wakayama; Minoru Shinozaki; Kyoko Gocho; Yoshinobu Hata; Takao Ishiwatari; Tetsuo Nemoto; Kazutoshi Shibuya
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.